Sign inJoin waitlistJoin the waitlist

AM

Autumn McRee

Hematology & Oncology

Credentials: · ·

History

Hematology and Medical Oncology
2010–2013
Internal Medicine
2007–2010
McGovern Medical School at The University of Texas Health Science Center at Houston
2001–2005

Research

Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
The Lancet Oncology · 2016 · 907 citations
Combined BRAF, EGFR, and MEK Inhibition in Patients with BRAFV600E-Mutant Colorectal Cancer
Cancer Discovery · 2018 · 499 citations
Integrative Genomic Analysis of Cholangiocarcinoma Identifies Distinct IDH-Mutant Molecular Profiles
Cell Reports · 2017 · 414 citations

Bert O'Neil
12 papers
Hanna Sanoff
8 papers
Ashwin Somasundaram
3 papers
JB
Jeremiah Boles
3 papers
JB
Johanna Bendell
3 papers
Jonathan Sorah
3 papers
RG
Richard Goldberg
3 papers
William Kim
3 papers
Aaron Scott
2 papers · 1 as a fellow
Andrew Wang
2 papers
Angela Alistar
2 papers
CC
Cheryl Carlson
2 papers

Grants

Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $591.7K · Univ of North Carolina Chapel Hill
1997–2025

Clinical trials

hTERT Immunotherapy Alone or in Combination With IL-12 DNA Followed by Electroporation in Adults With Solid Tumors at High Risk of Relapse
Principal investigator · Completed · Phase 1
Inovio Pharmaceuticals
2014–2018
BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer
Principal investigator · Completed · Phase 1
UNC Lineberger Comprehensive Cancer Center
2012–2016
Crossover Evaluation of Effect of Atorvastatin on PK of Irinotecan in CRC Patients Receiving FOLFIRI
Principal investigator · Withdrawn · Phase 1
UNC Lineberger Comprehensive Cancer Center
2012–2014
FOLFIRINOX for Unresectable Locally Advanced and Borderline Resectable Pancreatic Cancer
Principal investigator · Terminated · Phase 2
UNC Lineberger Comprehensive Cancer Center
2012–2016